COX-2 expression correlates with microvessel density in non-melanoma skin cancer from renal transplant recipients and immunocompetent individuals

Human Pathology

Volumn 35, Issue 12, 2004, Pages 1549-1555

  O'Grady, Anthony ^a,b   O'Kelly, Patrick ^a   Murphy, Gillian M ^a   Leader, Mary ^a   Kay, Elaine ^a  

^a BEAUMONT HOSPITAL   (Ireland)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

angiogenesis; basal cell carcinoma; BCC; BD; Bowen's disease; COX 2; cyclooxygenase 2; high power field; HPF; ICI; immunocompetent individual; microvessel density; MVD; skin cancer; squamous cell carcinoma

Indexed keywords

CYCLOOXYGENASE 2; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BASAL CELL CARCINOMA; BOWEN DISEASE; CONTROLLED STUDY; CORRELATION FUNCTION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MICROVASCULATURE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RECIPIENT; SKIN CANCER; SQUAMOUS CELL CARCINOMA; TUMOR VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CYCLOOXYGENASE 2; FEMALE; HUMANS; IMMUNOCOMPETENCE; ISOENZYMES; KIDNEY TRANSPLANTATION; MALE; MEMBRANE PROTEINS; MICROCIRCULATION; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; POSTOPERATIVE COMPLICATIONS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SKIN NEOPLASMS;

EID: 10944260550     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2004.08.010     Document Type: Article

References (34)

1. Stockfleth E., Ulrich C., Meyer T., et al. Skin diseases following organ transplantation Risk factors and new therapeutic approaches. Transplant Proc. 33:2001;1848-1853
2. Hartevelt M.M., Bavinck J.N., Kootte A.M., et al. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation. 49:1990;506-509
3. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst. 82:1990;4-6
4. Hanahan D., Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 86:1996;353-364
5. Isoherranen K., Punnonen K., Jansen C., et al. Ultraviolet irradiation induces cyclooxygenase-2 expression in keratinocytes. Br J Dermatol. 140:1999;1017-1022
6. Tsujii M., Kawano S., Tsuji S., et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell. 93:1998;705-716
7. Jones M.K., Wang H., Peskar B.M., et al. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med. 5:1999;1418-1423
8. Vermeulen P.B., Verhoeven D., Hubens G., et al. Microvessel density, endothelial cell proliferation and tumor cell proliferation in human colorectal adenocarcinomas. Ann Oncol. 6:1995;59-64
9. Fox S.B., Gatter K.C., Bicknell R., et al. Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer. Cancer Res. 53:1993;4161-4163
10. Mattern J., Koomagi R., Volm M. Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumor cell proliferation in human epidermoid lung carcinoma. Br J Cancer. 73:1996;931-934
11. Vermeulen P.B., Gasparini G., Fox S.B., et al. Quantification of angiogenesis in solid human tumors: an international consensus on the methodology and criteria of evaluation. Eur J Cancer. 32A:1996;2474-2484
12. Gundersen H.J., Bendtsen T.F., Korbo L., et al. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS. 96:1988;379-394
13. Chin C.W., Foss A.J., Stevens A., et al. Differences in the vascular patterns of basal and squamous cell skin carcinomas explain their differences in clinical behavior. J Pathol. 200:2003;308-313
14. Brown L.F., Berse B., Jackman R.W., et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol. 26:1995;86-91
15. Guidi A.J., Abu-Jawdeh G., Berse B., et al. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. J Natl Cancer Inst. 87:1995;1237-1245
16. Weninger W., Uthman A., Pammer J., et al. Vascular endothelial growth factor production in normal epidermis and in benign and malignant epithelial skin tumors. Lab Invest. 75:1996;647-657
17. Newell B., Bedlow A.J., Cliff S., et al. Comparison of the microvasculature of basal cell carcinoma and actinic keratosis using intravital microscopy and immunohistochemistry. Br J Dermatol. 149:2003;105-110
18. Yano K., Oura H., Detmar M. Targeted overexpression of the angiogenesis inhibitor thrombospondin-1 in the epidermis of transgenic mice prevents ultraviolet-B-induced angiogenesis and cutaneous photo damage. J Invest Dermatol. 118:2002;800-805
19. Strieth S., Hartschuh W., Pilz L., et al. Angiogenic switch occurs late in squamous cell carcinomas of human skin. Br J Cancer. 82:2000;591-600
20. Streit M., Riccardi L., Velasco P., et al. Thrombospondin-2 A potent endogenous inhibitor of tumor growth and angiogenesis. Proc Natl Acad Sci U S A. 96:1999;14888-14893
21. Oh C.K., Kwon Y.W., Kim Y.S., et al. Expression of basic fibroblast growth factor, vascular endothelial growth factor, and thrombospondin-1 related to microvessel density in nonaggressive and aggressive basal cell carcinomas. J Dermatol. 30:2003;306-313
22. Staibano S., Boscaino A., Salvatore G., et al. The prognostic significance of tumor angiogenesis in nonaggressive and aggressive basal cell carcinoma of the human skin. Hum Pathol. 27:1996;695-700
23. Weninger W., Rendl M., Pammer J., et al. Differences in tumor microvessel density between squamous cell carcinomas and basal cell carcinomas may relate to their different biologic behavior. J Cutan Pathol. 24:1997;364-369
24. Joo Y.E., Rew J.S., Seo Y.H., et al. Cyclooxygenase-2 overexpression correlates with vascular endothelial growth factor expression and tumor angiogenesis in gastric cancer. J Clin Gastroenterol. 37:2003;28-33
25. Davies G., Salter J., Hills M., et al. Correlation between cyclooxygenase-2 expression and angiogenesis in human breast cancer. Clin Cancer Res. 9:2003;2651-2656
26. Kase S., Osaki M., Honjo S., et al. Expression of cyclooxygenase-2 is correlated with high intratumoral microvessel density and low apoptotic index in human esophageal squamous cell carcinomas. Virchows Arch. 442:2003;129-135
27. Futagami A., Ishizaki M., Fukuda Y., et al. Wound healing involves induction of cyclooxygenase-2 expression in rat skin. Lab Invest. 82:2002;1503-1513
28. Detmar M., Velasco P., Richard L., et al. Expression of vascular endothelial growth factor induces an invasive phenotype in human squamous cell carcinomas. Am J Pathol. 156:2000;159-167
29. Yoshida S., Amano H., Hayashi I., et al. COX-2/VEGF-dependent facilitation of tumor-associated angiogenesis and tumor growth in vivo. Lab Invest. 83:2003;1385-1394
30. Kagoura M., Toyoda M., Matsui C., et al. Immunohistochemical expression of cyclooxygenase-2 in skin cancers. J Cutan Pathol. 28:2001;298-302
31. Leong J., Hughes-Fulford M., Rakhlin N., et al. Cyclooxygenases in human and mouse skin and cultured human keratinocytes Association of COX-2 expression with human keratinocyte differentiation. Exp Cell Res. 224:1996;79-87
32. Renkonen J., Wolff H., Paavonen T. Expression of cyclooxygenase-2 in human tongue carcinoma and its precursor lesions. Virchows Arch. 440:2002;594-597
33. Viac J., Palacio S., Schmitt D., et al. Expression of vascular endothelial growth factor in normal epidermis, epithelial tumors and cultured keratinocytes. Arch Dermatol Res. 289:1997;158-163
34. Smith K.J., Germain M., Skelton H. Bowen's disease (squamous cell carcinoma in situ) in immunosuppressed patients treated with imiquimod 5% cream and a COX inhibitor, sulindac Potential applications for this combination of immunotherapy. Dermatol Surg. 27:2001;143-146